Joe Moscato As well as license some new technol
Post# of 36537
As well as license some new technologies that we're in deep discussions with
now. As well as partner with another large biopharmaceutical company that
has other great synergies with our technologies. We're hoping that within the
next 60 to 90 days, NuGenerex Immuno-Oncology will be public